Our latest updates
22 Dec, 2025
The global testicular cancer drugs market size is valued at USD 1.15 billion in 2025. North America held a dominant share of the global market, accounting for 43.24%.
22 Dec, 2025
The global joint reconstruction devices market size is valued at USD 29.48 billion in 2025. North America held a dominant share of the global market, accounting for 48.78%.
22 Dec, 2025
The global Insomnia Supplements Market size is valued at USD 5.01 billion in 2025. North America held a dominant share of the global market, accounting for 37.24%.
22 Dec, 2025
The global immune health supplements market size is valued at USD 38.19 billion in 2025. North America held a dominant share of the global market, accounting for 38.24% share in 2025.
22 Dec, 2025
The global robotic radiotherapy market size is valued at USD 1.52 billion in 2025. North America dominated the market, accounting for 37.49% of market share in 2025
22 Dec, 2025
The global hematocrit testing market size is valued at USD 2.05 billion in 2025. North America dominated the global market, accounting for 39.05% share in 2025.
22 Dec, 2025
The global stem cell culture media market size is valued at USD 757.30 million in 2025. North America held a dominant share of the global market, accounting for 39.14% in 2025.
22 Dec, 2025
The global autism spectrum disorder treatment market size is valued at USD 2.31 billion in 2025. North America dominated the market, accounting for 42.09% share in 2025, due to widespread awareness of autism spectrum disorders.
22 Dec, 2025
The global spheroids market size is valued at USD 915.02 million in 2025. North America held a dominant share of the global market, accounting for 38.14% in 2025.
22 Dec, 2025
The global viral filtration market size is valued at USD 6.54 billion in 2025. North America held a dominant share of the global market, accounting for 43.24% share in 2025.
22 Dec, 2025
The global isothermal nucleic acid amplification technology market size is valued at USD 5.73 billion in 2025. North America held a dominant share of the global market, accounting for 45.84% in 2025.
22 Dec, 2025
The global SGLT2 inhibitors market size is valued at USD 13.43 billion in 2025. North America dominated the market, accounting for 41.02% of the market share in 2025